Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design

被引：36

作者：

Cross, Jason B. ^{[1
]}

Zhang, Jing ^{[1
]}

Yang, Qingyi ^{[1
]}

Mesleh, Michael F. ^{[1
]}

Romero, Jan Antoinette C. ^{[1
]}

Wang, Bin ^{[1
]}

Bevan, Doug ^{[1
]}

Poutsiaka, Katherine M. ^{[1
]}

Epie, Felix ^{[1
]}

Moy, Terence ^{[1
]}

Daniel, Anu ^{[1
]}

Shotwell, Joseph ^{[1
]}

Chamberlain, Brian ^{[1
]}

Carter, Nicole ^{[1
]}

Andersen, Ole ^{[2
]}

Barker, John ^{[2
]}

Ryan, M. Dominic ^{[1
]}

Metcalf, Chester A., III ^{[1
]}

Silverman, Jared ^{[1
]}

Nguyen, Kien ^{[1
]}

Lippa, Blaise ^{[1
]}

Dolle, Roland E. ^{[1
]}

机构：

[1] Cubist Pharmaceut Inc, 65 Hayden Ave, Lexington, MA 02421 USA

[2] Evotec UK Ltd, 114 Innovat Dr,Milton Pk, Abingdon OX14 4RZ, Oxon, England

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 04期

关键词：

Antibacterials; DNA gyrase B; fragment-based drug design; structure-based drug design; DNA GYRASE; ANTIBACTERIAL ACTIVITY; LEAD DISCOVERY; AGENTS; GYRB; OPTIMIZATION; MECHANISM; SCAFFOLD; POTENT;

D O I：

10.1021/acsmedchemlett.5b00368

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The ATPase subunit of DNA gyrase B is an attractive antibacterial target due to high conservation across bacteria and the essential role it plays in DNA replication. A novel class of pyrazolopyridone inhibitors was discovered by optimizing a fragment screening hit scaffold using structure guided design. These inhibitors show potent Gram-positive antibacterial activity and low resistance incidence against clinically important pathogens.

引用

下载

页码：374 / 378

页数：5

共 50 条

[31] Discovery of FAK Inhibitors Using Structure Based Drug Design
Nam, Ky-Youb
Jin, Dong-Hoon
No, Kyoung Tai
Ahn, Soon Kil
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2014, 35 (11) : 3156 - 3157
[32] Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
Panda, Manoranjan
Ramachandran, Sreekanth
Ramachandran, Vasanthi
Shirude, Pravin S.
Humnabadkar, Vaishali
Nagalapur, Kavitha
Sharma, Sreevalli
Kaur, Parvinder
Guptha, Supreeth
Narayan, Ashwini
Mahadevaswamy, Jyothi
Ambady, Anisha
Hegde, Naina
Rudrapatna, Suresh S.
Hosagrahara, Vinayak P.
Sambandamurthy, Vasan K.
Raichurkar, Anandkumar
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4761 - 4771
[33] In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B
Brvar, Matjaz
Perdih, Andrej
Hodnik, Vesna
Renko, Miha
Anderluh, Gregor
Jerala, Roman
Solmajer, Tom
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (08) : 2572 - 2580
[34] Structure-guided design of antibacterials that allosterically inhibit DNA gyrase
Thalji, Reema K.
Raha, Kaushik
Andreotti, Daniele
Checchia, Anna
Cui, Haifeng
Meneghelli, Giovanni
Profeta, Roberto
Tonelli, Federica
Tommasi, Simona
Bakshi, Tania
Donovan, Brian T.
Howells, Alison
Jain, Shruti
Nixon, Christopher
Quinque, Geoffrey
McCloskey, Lynn
Bax, Benjamin D.
Neu, Margarete
Chan, Pan F.
Stavenger, Robert A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1407 - 1412
[35] Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation
Tobe, M
Isobe, Y
Tomizawa, H
Nagasaki, T
Takahashi, H
Fukazawa, T
Hayashi, H
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (03) : 383 - 391
[36] Structure-based design of a novel class of herbicidal HPPD inhibitors
Viner, Russell
Bhonoah, Yunas
Langford, Mike
Kloer, Daniel
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[37] Discovery of a novel class of potent Raf kinase inhibitors: Structure activity relationships.
Lowinger, TB
Riedl, B
Wood, J
Dumas, J
Smith, RA
Khire, U
Bankston, D
Monahan, MK
Scott, WJ
Lee, W
Johnson, JS
Caringal, Y
Turner, T
Gane, T
Kennure, N
Barbosa, J
CLINICAL CANCER RESEARCH, 2000, 6 : 4533S - 4533S
[38] Discovery of novel orally bioavailable renin inhibitors by structure based drug design
Edmunds, Jeremy J.
Belliotti, Thomas
Bryant, John
Cai, Cuiman
Cheng, Xue Min
Ciske, Fred L.
Cody, Wayne L.
Collard, Wendy
Downing, Dennis M.
Erasga, Noe
Ferreira, Suzie
Hall, Eric
Holsworth, Daniel D.
Jalaie, Mehran
Kasani, Aparna
Kaufman, Michael
Lee, Chitase
Li, Tingsheng
Maiti, Samarendra
McConnell, Patrick
Mennen, Ken
Ostroski, Robert
Powell, Noel A.
Quinn, John, III
Rahim, Mohammad
Ryan, Michael
Stier, Michael A.
Subedi, Rajandra
Van Huis, Chad
Zhang, Erli
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[39] Discovery of novel SecA inhibitors of Candidatus Liberibacter asiaticus by structure based design
Akula, Nagaraju
Zheng, Hong
Han, Frank Q.
Wang, Nian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (14) : 4183 - 4188
[40] Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases
Huang, P
Ramphal, J
Wei, J
Liang, CX
Jallal, B
McMahon, G
Tang, C
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (08) : 1835 - 1849

← 1 2 3 4 5 →